Clarification of the cardiomyopathies.
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000437:Alcoholism / Q000150:complications; D009202:Cardiomyopathies / Q000145:classification / Q000150:complications / Q000209:etiology / Q000276:immunology / Q000503:physiopathology; D002312:Cardiomyopathy, Hypertrophic / Q000473:pathology / Q000503:physiopathology; D003384:Coxsackievirus Infections / Q000150:complications; D004719:Endomyocardial Fibrosis / Q000503:physiopathology; D005260:Female; D006333:Heart Failure / Q000150:complications / Q000209:etiology / Q000276:immunology / Q000503:physiopathology; D006352:Heart Ventricles / Q000187:drug effects; D006801:Humans; D006973:Hypertension / Q000150:complications; D007251:Influenza, Human / Q000150:complications; D008297:Male; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular; D011644:Puerperal Disorders
D000319:Adrenergic beta-Antagonists